Activity

  • Public Info posted an update 3 years ago

    InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Featured in InvestmentPitch Media Video

    InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Featured in InvestmentPitch Media Video

    Home / InvestorWire NewsRoom / InvestorNewsBreaks /
    September 22, 2023
    InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Featured in InvestmentPitch Media Video
    FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a company building a portfolio of innovative assets and biotech solutions, was featured in an InvestmentPitch media video that discusses continued development of UNBUZZD(TM), the company’s new rapid detox drink. UNBUZZD(TM) is a proprietary formulation of natural ingredients, vitamins and minerals to help relieve the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle. Kevin Harrington, an original “shark” on the TV hit show Shark Tank and the creator of the infomercial to introduce UNBUZZD(TM), joined the program to discuss his involvement with the product and the impressive team he put together that has cumulatively generated billions of dollars of sales and value for brands and shareholders.
    To view the full press release, visit https://ibn.fm/GExQd
    About FSD Pharma Inc.
    FSD Pharma is a biotechnology company with two candidates in different stages of development. Lucid Psychss Inc., a wholly owned subsidiary, is focused on the research and development of its lead compounds, Lucid-MS and UNBUZZD(TM). Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle. For more information, visit the company’s website at http://www.FSDPharma.com.
    About InvestorWire
    InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
    For more information, please visit https://www.InvestorWire.com
    Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
    InvestorWire
    Los Angeles, CA
    http://www.InvestorWire.com
    310.299.1717 Office
    Editor@InvestorWire.com
    InvestorWire is powered by IBN

    Video courtesy of Eurex